Deals channel feed – Endpoints News

Deals channel feed

Arcus touts early kidney cancer data as Gilead declines option

3 months ago

After research pivot, Biogen beefs up pipeline with Stoke's late-stage Dravet candidate

3 months ago

How Bain’s $3.3B deal for centuries-old Tanabe Pharma came to fruition

3 months ago

Idorsia’s Tryvio licensing negotiations collapse amid cash squeeze

3 months ago

Sanofi faces $250M charge after J&J-partnered vaccine flunks late-stage test

3 months ago

Newleos, a new biotech with $93.5M, repurposes Roche's experimental CNS drugs

3 months ago

Biogen gets $250M in Royalty Pharma deal for Phase 3 lupus program

3 months ago

Novartis returns for its anticoagulant in up to $3.1B buy of Blackstone’s Anthos

3 months ago

Eli Lilly inks $630M deal for Phase 1 MASH candidate

3 months ago

Decade after $8B deal, Roche offloads InterMune to mysterious specialty pharma

3 months ago

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan

3 months ago

Less than two years after blockbuster IPO, Acelyrin merges with Alumis to combine cash, assets

3 months ago

J&J, Intra-Cellular quickly sealed $14B deal as three others passed on buying the neuro drugmaker

3 months ago

Teladoc to buy Catapult Health for $65M

3 months ago

Revance and Crown are almost ready to close their deal after earlier bidding war

3 months ago

Pfizer says it has at least $10B available for deals in 2025, with a focus on pipeline

3 months ago

Biogen’s revised research strategy is to avoid becoming obsolete, top exec says

3 months ago

Roche aims for derisked deals and ruthless portfolio cuts in 2025

3 months ago

Sanofi is in the market for M&A, thanks to ‘strong’ balance sheet

3 months ago

Lonza looks to buy facilities and tech to boost service offerings

3 months ago

Lantheus to buy radiopharma CDMO and diagnostic assets for $250M upfront

3 months ago

Sage turns down Biogen's buyout offer and will look at other options

3 months ago

Exclusive: Leerink builds healthcare M&A team, poaching dealmakers from rivals

3 months ago

Agenus continues partnership talks for anti-CTLA-4 combo with new Phase 2 data

4 months ago

First page Previous page 2 3 456 7 8 Next page Last page